Each year, thousands of people just like you begin a personal journey when they are diagnosed with metastatic breast, colorectal, or prostate cancer. Now there is a test that can predict your prognosis at any time along your journey, and help your doctor in guiding your way. It's called the CellSearch™ Circulating Tumor Cell Test.

For patients undergoing sentinel lymph node testing, the GeneSearch™ Breast Lymph Node Assay is the first molecular test approved for the rapid detection of metastases greater than 0.2 mm in sentinel lymph node tissue offering the chance for fewer second surgeries and hospital stays.